智通财经APP讯,和铂医药-B(02142)发布公告,配售的所有条件已获达成,且配售已于2025年9月5日完成。根据配售协议的条款及条件,配售代理已成功以每股配售股份11.50港元的配售价向不少于六名承配人配售4502.2万股配售股份。
智通财经APP讯,和铂医药-B(02142)发布公告,配售的所有条件已获达成,且配售已于2025年9月5日完成。根据配售协议的条款及条件,配售代理已成功以每股配售股份11.50港元的配售价向不少于六名承配人配售4502.2万股配售股份。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.